AXIM BIOTECHNOLOGIES

HISTORY

We were incorporated in the state of Nevada on November 18, 2010, as AXIM International, Inc. On July 24, 2014, we changed our name to AXIM Biotechnologies, Inc. to better reflect our current, expanded business operations. In early 2014, we discontinued our organic waste marketable by-product business to focus on our anticipated new business to become an innovative biotechnology company working on the treatment of pain, spasticity, anxiety, and other medical disorders with the application of known and novel cannabinoid-based products. Our focus is also on research, development and production of pharmaceutical, nutraceutical and cosmetic products as well as procurement of genetically and nano-controlled active ingredients.

STRATEGY

STRATEGY

We discover and bring to market innovative solutions through research and development, strategic partnerships and acquisitions.

MANUFACTURING

MANUFACTURING

AXIM is building a state of the art extraction and manufacturing facility in the city of Almere, The Netherlands.

FAQs

FAQs

AXIM Biotech is involved in all four major industrial areas: health care, agriculture, non-food uses of botanicals, such as biofuels as well as environmental uses.